Profile

Dr (MD) Laura Kim

Charité - University Medicine Berlin, Germany

Presentation

11:20 CEST / Session: Treatment II: Clinical trials

Hyperbaric oxygen therapy (HBOT) trial in ME/CFS

Dr Laura Kim was previously acting as a physician and researcher at the Institute of Medical Immunology at Charité – University Medicine Berlin in Germany, where she was a member of Prof Carmen Scheibenbogen's research group on "Clinical Immunology and Immune Monitoring". In her previous role, she acted as the coordinator of several clinical trials implemented within the framework of the National Clinical Studies Group ME/CFS and Post-COVID Syndrom (NKSG) at Charité.

Laura Kim